E. Erhardt et al., Correlation of blood-spot 17-hydroxyprogesterone daily profiles and urinary steroid profiles in congenital adrenal hyperplasia, J PED END M, 13(2), 2000, pp. 205-210
Objective: To compare the value of blood-spot 17-hydroxyprogesterone (17-OH
P) daily profiles and urinary steroid excretion in untreated and treated pa
tients with congenital adrenal hyperplasia (CAH),
Patients: Ten patients with CAH were investigated during steroid replacemen
t therapy (Group 1), and 11 patients were investigated without treatment (G
roup 2),
Methods: Capillary blood samples were collected for measurement of blood-sp
ot 17-OHP values by non-chromatographic radioimmunoassay, Steroid profiles
of 24-h urine samples were analyzed by gas chromatography.
Results: There was a close correlation between the individual daily means o
f blood-spot 17-OHP measurements and the pregnanetriol/tetrahydrocortisone
ratio in both groups of patients (Group 2: r = 0,839, p < 0,001; Group 1: r
= 0,686, p < 0,001), Almost the same correlation was found between the blo
od-spot 17-OHP value and the sum of three 17-hydroxyprogesterone metabolite
s/the sum of three cortisol/cortisone metabolites ratio (Group 2: r = 0,918
, p < 0,001; Group 1: r = 0,741, p < 0,001),
Conclusions: Blood-spot 17-OHP measurements and 24-h urinary steroid profil
e have the same impact in identification and monitoring therapy of children
with CAH.